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Summary: Of five anti-Salmonella porcine cultures administered to pigs at 1010 cfu/day, two Lactobacillus
murinus strains demonstrated superior survival during gastrointestinal transit. Both were detected at
~107-108 cfu/g faeces which was higher (P<0.05) than Pediococcus pentosaceus DPC6006 (~105 cfu/g).
One Lb. murinus strain was also excreted at higher numbers (P<0.05) than either Lb. salivarius DPC6005
or Lb. pentosus DPC6004 (both ~106 cfu/g). The Lb. murinus strains persisted in both the faeces and
the caecum for at least 9 days post-administration. Animals fed a combination of all five strains at
1010 cfu/day excreted ~107 cfu/g of the administered strains, which was higher (P<0.05) than only P.
pentosaceus DPC6006. Randomly amplified polymorphic DNA (RAPD) PCR analysis revealed that
both Lb. murinus strains predominated in the faeces of these animals during administration, while
post-administration, both Lb. murinus strains and Lb. pentosus DPC6004 were recovered from the
faeces and the caecum while P. pentosaceus DPC6006 was only detected in the caecum. After 21
days of culture administration, faecal Enterobacteriaceae counts were reduced in pigs fed Lb.
salivarius DPC6005, P. pentosaceus DPC6006, Lb. pentosus DPC6004 and the culture mix, though not
significantly. Overall, the porcine intestinal isolates offer potential as probiotics for enteropathogen
reduction in pigs; possibly as a combination due to strain variation.
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Introduction: Probiotics aimed at restoration and maintenance of a healthy gut microflora offer
potential as a means of controlling enteric pathogen carriage in pigs. Competitive exclusion cultures
are particularly effective in pigs (Nisbet, 2002). However, uncertainty regarding their exact composition
has led to concerns that they may result in pathogen transmission and could also hinder regulatory
approval. Alternatively, defined probiotic strains, most commonly lactic acid bacteria, Bacillus or
yeast, can be used as feed additives, either individually or as mixtures. However, commercial animal
probiotic products do not always contain the strains or species listed on the label at an adequate
dose or may lack evidence of a probiotic effect (Weese, 2002), highlighting the need for proper
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selection and characterisation of strains intended for probiotic use. Furthermore, although interest
is increasing in the use of probiotics as microbial feed additives for pathogen reduction in pigs,
relatively few strains have demonstrated efficacy in vivo. The objective of this study was to investigate
intestinal performance of five potentially probiotic porcine caecal isolates with anti-Salmonella
activity (Casey et al., 2003), when orally administered both individually and as a five-strain combination. 
Materials and Methods: Twenty eight pigs weaned at 24-28 days were blocked on sex and weight
and assigned at random to one of seven treatments (n=4): (1) control (no culture), (2) Lb. salivarius
DPC6005, (3) P. pentosaceus DPC6006, (4) Lb. pentosus DPC6004, (5) Lb. murinus DPC6002, (6) Lb.
murinus DPC6003 and (7) mixture of all five cultures. Rifampicin resistant (Rifr) variants of each strain,
required for enumeration were administered as skim milk fermentates containing ~108 cfu/ml. The
feeding trial consisted of three consecutive periods; 10 days baseline (100 ml sterile skim milk
supplemented with 0.5 % (w/v) yeast extract per day), 21 days culture administration (100 ml fermentate
providing ~3 ~1010 cfu/day relevant strain(s) for treatments 2-7 and 100 ml lactic acid-acidified sterile
skim milk per day for control pigs) and 9 days post-administration (no milk or culture). Animals also
had unrestricted access to water and non-medicated creep feed. Faecal samples were obtained
during the baseline (day -5), administration (days 3, 8, 15 and 22) and post-administration (day 26)
periods. At day 30 two pigs per treatment were sacrificed and the caecal contents sampled. Faecal
and caecal samples were homogenised in maximum recovery diluent as 1:10 dilutions, further diluted
and pour-plated. MRS agar containing 100 mg/ml of rifampicin (MRS-RIF) incubated anaerobically
at 37 ÆC for 2 days was used to enumerate the administered strains, while Enterobacteriaceae were
enumerated on violet red bile glucose agar incubated at 37 ÆC for 24 h. Representative colonies from
MRS-RIF plates from faecal and caecal samples were genetically fingerprinted by RAPD PCR as
described previously (Gardiner et al., 1998). The data were statistically analysed using Genstat and
Tukey’s Test was used for separation of means.
Results: During the 21-day administration period all animals excreted 105-108 cfu/g of the administered
strains (Table 1), as confirmed by genetic fingerprinting of representative faecal isolates using RAPD
PCR. However, the Lb. murinus strains DPC6003 and DPC6002 demonstrated superior survival, yielding
the highest mean faecal excretion of all individually administered strains (Table 1) and accounting
for 21-24 % of total faecal lactobacilli. The mean counts for both Lb. murinus strains during the 21-
day administration period (day 3-22) were higher (P<0.05) than those of P. pentosaceus DPC6006,
which had the lowest mean faecal count (Table 1). The mean faecal day 3-22 count of Lb. murinus
DPC6003 was also higher (P<0.05) than Lb. salivarius DPC6005 and Lb. pentosus DPC6004 (Table 1),
both of which represented on average only 1.1-1.3 % of total faecal lactobacilli. Animals fed the five-
strain combination excreted high counts of the administered strains and the mean count during the
administration period was higher (P<0.05) than that of P. pentosaceus DPC6006 (Table 1), with both
Lb. murinus strains or Lb. murinus DPC6003 alone predominating, as determined by RAPD PCR (data
not shown). Although faecal counts of the administered strains declined once administration stopped,
all animals fed the Lb. murinus cultures or the strain combination still harboured high levels of the
administered strains at day 5 post-administration (Table 1), with the predominating isolates in the
mixture-fed animals identified by RAPD as either Lb. murinus DPC6002 or DPC6003 or Lb. pentosus
DPC6004 (data not shown). These treatment groups also harboured highest levels of the administered
strains (103-106 cfu/g) in the caecum 9 days post-administration, with the Lb. murinus strains
predominating in one of the mixture-fed animals sacrificed and Lb. pentosus DPC6004 and P.
pentosaceus DPC6006 in the other (data not shown). In comparison, strains DPC6006, DPC6004 and
DPC6005, when administered individually persisted less well in both the faeces and the caecum. 
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Table 1. Mean faecal counts (log cfu/g) of administered strains in pigs fed ~1010 cfu/day of skim milk
fermentates of each of the porcine cultures singly or as a combination
On average, when all treatment groups were analysed together faecal Enterobacteriaceae were lower
(P<0.05) towards the end of the culture administration period (day 15, 22 and 26) than prior to or during
the first week (day -5, 3 and 8) (data not shown). However, no significant effects on faecal Enterobacteriaceae
were obtained when the entire culture administration period (day 3-22) was analysed, probably because
counts were highly variable within individual treatment groups and fluctuated throughout the trial.
However, at day 15 mean faecal Enterobacteriaceae were lower (P<0.05) in animals fed Lb. murinus
DPC6003 than in animals fed Lb. murinus DPC6002 or the culture mix (Table 2). Furthermore, when mean
pre-administration counts were compared with counts after 21 days of culture administration, 87-98 %
reductions in Enterobacteriaceae were obtained in pigs fed Lb. salivarius DPC6005, P. pentosaceus
DPC6006, Lb. pentosus DPC6004 and the culture mix (Table 2), although the results were not statistically
significant. Counts also decreased by 83 % in the control group fed acidified skim milk.
Table 2. Effect of culture administration on mean faecal Enterobacteriaceae counts (log cfu/g) in pigs
Discussion: Survival during intestinal transit and colonization of the gut are important criteria for orally
administered probiotics. The strains isolated in our laboratory performed well, especially Lb. murinus,
which accounted for a large percentage of total faecal lactobacilli, in comparison with previously
administered lactobacilli (24 % vs. 2.5 %) (Pedersen et al., 1992). The strains administered persisted, albeit
to varying degrees, in the faeces and the caecum for at least 5 and 9 days post-administration,
respectively, which compares well with previous reports of 3-7 days faecal persistence for other lactobacilli
(Pedersen et al., 1992). These findings demonstrate that the porcine isolates compete effectively with
the native microflora and become established in the intestine to some extent. The strain variation with
respect to survival and persistence in the porcine gut has previously been observed (Pedersen et al.,
1992), suggesting that there may be advantages to feeding a culture mix. Indeed, individual strains within
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a mix survived differently in individual animals and in general, the culture combination resulted in good
survival and persistence, as previously observed by Pedersen et al. (1992). Many studies have reported
reductions in intestinal coliform and Enterobacteriaceae due to probiotic administration; however,
some have seen no effects (Simon et al., 2003). In the present study most of the cultures resulted in
reductions in faecal Enterobacteriaceae; in fact, reductions of up to 98 % were observed. However,
except for day 15, these reductions were not statistically significant, probably due to the variation in
counts between individual animals, a common observation in probiotic animal trials. This inconsistency
may be explained by individual variations in response to probiotics due to the complexity of the intestine
(Simon et al., 2003). Future experiments using larger treatment groups and deliberate Salmonella infection
should provide further information on the pathogen-lowering ability of these cultures.
Conclusions: Pig-derived potentially probiotic cultures with anti-Salmonella activity can be effectively
delivered to the porcine intestine by oral administration, either individually or as a strain combination.
However, it was evident that certain cultures survived at higher levels, persisted for longer in the caecum
post-administration and were more effective in reducing pathogenic indicator species, highlighting the
advantages of using combination probiotics in pigs. We conclude that, although further characterisation
of efficacy is necessary, the findings provide a basis to further explore the potential of these porcine isolates
as microbial feed additives (most likely administered as a mixture) for Salmonella reduction in pigs.
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Summary: Macrophages are thought to play a major role in the development of Salmonella carriers
in swine. It was the aim of the present study to characterize the interactions of a Salmonella serovar
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